This is explained by the fact that secondary signal transducers correlated to tumor suppressors (such as SIRT1) or potential oncogens (for example, mTOR, and KRAS) behave pleiotropically depending on the tissue or cell type. The gene discussed is KRAS; the disease is neoplasm.